A Case Report with Plasmablastic Lymphoma of the Jejunum

被引:27
作者
Cha, Jae Myung [1 ]
Lee, Joung Il
Joo, Kwang Ro
Jung, Sung Won
Shin, Hyun Phil
Lee, Jae Jin
Kim, Gyo Young [2 ]
机构
[1] Univ Kyunghee, Coll Med, Dept Internal Med, EW Neo Med Ctr, 149 Sangil Dong, Seoul 134727, South Korea
[2] Univ Kyunghee, Coll Med, Dept Pathol, Seoul 134727, South Korea
关键词
HIV-negative; Jejunum; Plasmablastic Lymphoma; ORAL-CAVITY; ENTITY;
D O I
10.3346/jkms.2010.25.3.496
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasmablastic lymphoma (PBL) is a recently identified entity that is considered to be a type of diffuse large B-cell lymphoma with a unique immunophenotype and a predilection for the oral cavity of patients with the human immunodeficiency virus (HIV). Although its clinical features may help in the differential diagnosis, an extraoral location in a patient without HIV makes it more difficult to suspect clinically. This case report is the first to describe a patient with PBL originating from the jejunum in a 60-yr-old, HIV-seronegative man. Computed tomography of the face, chest and abdomen showed about a 9.4x9.0 cm mass of the proximal jejunum, multiple masses in the musculoskeletal soft tissue, and multiple lymphadenopathies. The histological examinations demonstrated a large cell lymphoma with plasmablastic differentiation. The neoplastic cells were diffusely positive for MUM1, epithelial membrane antigen and lambda light chains, and focally positive for CD79a; but negative for CD3, CD20, CD30, CD34, CD45RO, CD56, CD99, and CD117. The proliferation index by Ki-67 immunohistochemistry was approximately 70%. These findings were compatible with the diagnosis of PBL. The findings in this case suggest that PBL should be included in the differential diagnosis of a small bowel mass even in a HIV-negative patient.
引用
收藏
页码:496 / 500
页数:5
相关论文
共 9 条
[1]  
Brown R S, 1998, Clin Oncol (R Coll Radiol), V10, P327, DOI 10.1016/S0936-6555(98)80089-7
[2]   Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities [J].
Colomo, L ;
Loong, F ;
Rives, S ;
Pittaluga, S ;
Martínez, A ;
López-Guillermo, A ;
Ojanguren, J ;
Romagosa, V ;
Jaffe, ES ;
Campo, E .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (06) :736-747
[3]   Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection [J].
Delecluse, HJ ;
Anagnostopoulos, I ;
Dallenbach, F ;
Hummel, M ;
Marafioti, T ;
Schneider, U ;
Huhn, D ;
SchmidtWesthausen, A ;
Reichart, PA ;
Gross, U ;
Stein, H .
BLOOD, 1997, 89 (04) :1413-1420
[4]   A monoclonal antibody (MUM1p) detects expression of the MUM 1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells [J].
Falini, B ;
Fizzotti, M ;
Pucciarini, A ;
Bigerna, B ;
Marafioti, T ;
Gambacorta, M ;
Pacini, R ;
Alunni, C ;
Natali-Tanci, L ;
Ugolini, B ;
Sebastiani, C ;
Cattoretti, G ;
Pileri, S ;
Dalla-Favera, R ;
Stein, H .
BLOOD, 2000, 95 (06) :2084-2092
[5]   Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations [J].
Flaitz, CM ;
Nichols, CM ;
Walling, DM ;
Hicks, MJ .
ORAL ONCOLOGY, 2002, 38 (01) :96-102
[6]  
Harris N L, 2000, Hematol J, V1, P53, DOI 10.1038/sj.thj.6200013
[7]  
Lin Y, 2001, ARCH PATHOL LAB MED, V125, P282
[8]  
Pruneri G, 1998, HAEMATOLOGICA, V83, P87
[9]  
Riedel DJ, 2008, LANCET INFECT DIS, V8, P261, DOI 10.1016/S1473-3099(08)70067-7